Cordyceps Sunshine Biotech Holdings (RAJAF) Non-Current Assets (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Non-Current Assets history runs 6 years deep, the most recent figure standing at $3.7 million for Q4 2025.

• In Q4 2025, Non-Current Assets fell 9.01% year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $12.5 million (up 19.78% YoY), while the FY2025 annual figure was $3.7 million, down 9.01% from the prior year.
• Non-Current Assets was $3.7 million for Q4 2025 at Cordyceps Sunshine Biotech Holdings, down from $4.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $4.0 million in Q4 2024 to a low of $1.6 million in Q4 2022.
• Historically, Non-Current Assets has averaged $2.7 million across 5 years, with a median of $2.6 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Non-Current Assets decreased 24.81% in 2022, then jumped 88.65% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $2.1 million in 2021, then slipped by 24.81% to $1.6 million in 2022, then surged by 88.65% to $3.0 million in 2023, then surged by 32.98% to $4.0 million in 2024, then retreated by 9.01% to $3.7 million in 2025.
• The last three Non-Current Assets figures came in at $3.7 million (Q4 2025), $4.0 million (Q4 2024), and $3.0 million (Q4 2023), per Business Quant data.